Takimoto, Riko <br/><br/>
No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.  [electronic resource] 

 -  European journal of dermatology : EJD  02 2018 
 - 84-85 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1952-4013 
<br/><br/><label>Standard No.: </label>10.1684/ejd.2017.3151  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Drug Substitution<br/>Female<br/>Humans<br/>Ipilimumab--therapeutic use<br/>Melanoma--drug therapy<br/>Nivolumab--adverse effects<br/>Purpura, Thrombocytopenic, Idiopathic--chemically induced<br/>Skin Neoplasms--drug therapy